Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock

52.35 EUR
+0.2 (+0.38%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, AKE scores 4 out of 10 in our fundamental rating. AKE was compared to 68 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
In the past year AKE had a positive cash flow from operations.
In the past 5 years AKE has always been profitable.
Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE has a Return On Assets (1.51%) which is in line with its industry peers.
AKE's Return On Equity of 2.90% is in line compared to the rest of the industry. AKE outperforms 52.94% of its industry peers.
AKE has a Return On Invested Capital (3.44%) which is comparable to the rest of the industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 7.01%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKE's Profit Margin of 2.22% is in line compared to the rest of the industry. AKE outperforms 54.41% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
With a Operating Margin value of 6.35%, AKE perfoms like the industry average, outperforming 57.35% of the companies in the same industry.
AKE's Operating Margin has declined in the last couple of years.
The Gross Margin of AKE (19.02%) is worse than 76.47% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AKE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AKE has an Altman-Z score of 1.87. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
AKE has a Altman-Z score of 1.87. This is in the lower half of the industry: AKE underperforms 72.06% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE's Debt to FCF ratio of 16.70 is in line compared to the rest of the industry. AKE outperforms 52.94% of its industry peers.
AKE has a Debt/Equity ratio of 0.50. This is a neutral value indicating AKE is somewhat dependend on debt financing.
The Debt to Equity ratio of AKE (0.50) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.87
ROIC/WACC0.72
WACC4.77%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE has a Current ratio of 2.73. This is amongst the best in the industry. AKE outperforms 80.88% of its industry peers.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.92, AKE belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
The Revenue has been growing slightly by 0.32% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

The Earnings Per Share is expected to decrease by -2.13% on average over the next years.
The Revenue is expected to grow by 1.37% on average over the next years.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.17, which indicates a very decent valuation of AKE.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 91.18% of the companies in the same industry.
AKE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
Based on the Price/Forward Earnings ratio of 9.76, the valuation of AKE can be described as reasonable.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 91.18% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (23.23), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 10.17
Fwd PE 9.76
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 94.12% of the companies in the same industry.
AKE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKE is cheaper than 79.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.54
EV/EBITDA 4.48
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

AKE's earnings are expected to decrease with -8.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)104.01
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%

6

5. Dividend

5.1 Amount

AKE has a Yearly Dividend Yield of 7.06%, which is a nice return.
Compared to an average industry Dividend Yield of 2.51, AKE pays a better dividend. On top of this AKE pays more dividend than 94.12% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.06%

5.2 History

On average, the dividend of AKE grows each year by 6.80%, which is quite nice.
Dividend Growth(5Y)6.8%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AKE pays out 129.52% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (1/2/2026, 7:00:00 PM)

52.35

+0.2 (+0.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners61.12%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.98B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts71.43
Price Target63.94 (22.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.06%
Yearly Dividend3.46
Dividend Growth(5Y)6.8%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-3.09%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-15.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-2.33%
Valuation
Industry RankSector Rank
PE 10.17
Fwd PE 9.76
P/S 0.42
P/FCF 17.54
P/OCF 3.92
P/B 0.55
P/tB 1.86
EV/EBITDA 4.48
EPS(TTM)5.15
EY9.84%
EPS(NY)5.36
Fwd EY10.25%
FCF(TTM)2.98
FCFY5.7%
OCF(TTM)13.36
OCFY25.52%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)104.01
Graham Number104.98
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.87
F-Score5
WACC4.77%
ROIC/WACC0.72
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 129.52%.